Financhill
Sell
33

GPCR Quote, Financials, Valuation and Earnings

Last price:
$21.05
Seasonality move :
47.59%
Day range:
$20.85 - $22.25
52-week range:
$19.39 - $62.74
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.44x
Volume:
325.3K
Avg. volume:
816.6K
1-year change:
-38.18%
Market cap:
$1.2B
Revenue:
--
EPS (TTM):
-$2.35

Earnings Data

Next earnings date for GPCR
May 09
2025
Most recent earnings per share
-$0.64
Missed by $0.47
(Feb 27/2025)
Consensus Estimate
-$0.17
(Feb 27/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GPCR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/09/2025 Q1 -- -- -- -$0.23 --
02/27/2025 Q4 -- -- -$0.64 -$0.17 -$0.47
11/13/2024 Q3 -- -- -$0.60 -$0.19 -$0.41
08/08/2024 Q2 -- -- -$0.54 -$0.23 -$0.32
05/09/2024 Q1 -- -- -$0.57 -$0.22 -$0.35
03/08/2024 Q4 -- -- -$0.48 -$0.21 -$0.27
11/17/2023 Q3 -- -- -$0.63 -$0.22 -$0.41
08/10/2023 Q2 -- -- -$0.60 -$0.27 -$0.33
05/11/2023 Q1 -- -- -$0.75 -$0.37 -$0.38
12/31/2022 Q4 -- -- -$0.31 -$0.54 $0.23
09/30/2022 Q3 -- -- -$0.49 -- --
06/30/2022 Q2 -- -- -$0.61 -- --
03/31/2022 Q1 -- -- -$0.51 -- --
12/31/2021 Q4 -- -- -$0.61 -- --

Structure Therapeutics Earnings Questions

  • How Much did Structure Therapeutics Generate in Revenue Last Quarter?

    Structure Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Structure Therapeutics Beat Earnings Last Quarter?

    Structure Therapeutics announced earnings per share of -$0.64 which represents a miss of analyst forecast a -$0.17 per share.

  • Is Structure Therapeutics Profitable?

    Structure Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Structure Therapeutics EPS Next Year?

    Structure Therapeutics's earnings are forecast to decrease from -$2.34 per share to -$0.76 per share next year representing a decrease of -70.86%.

  • When is Structure Therapeutics's Earnings Date?

    Structure Therapeutics's next earnings date is May 9, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Is Ford Stock Undervalued Amid the EV Transition?
Is Ford Stock Undervalued Amid the EV Transition?

There is a lot going on in the electric vehicle…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

Sell
47
CELH alert for Mar 18

Celsius Holdings [CELH] is up 1.44% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock